Vanguard Group Inc Harvard Bioscience Inc Transaction History
Vanguard Group Inc
- $5.12 Trillion
- Q2 2024
A detailed history of Vanguard Group Inc transactions in Harvard Bioscience Inc stock. As of the latest transaction made, Vanguard Group Inc holds 2,117,916 shares of HBIO stock, worth $4.98 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,117,916
Previous 2,152,147
1.59%
Holding current value
$4.98 Million
Previous $9.13 Million
33.85%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding HBIO
# of Institutions
105Shares Held
32MCall Options Held
1.2KPut Options Held
1.2K-
Black Rock Inc. New York, NY2.84MShares$6.68 Million0.0% of portfolio
-
Punch & Associates Investment Management, Inc. Edina, MN2.77MShares$6.51 Million0.49% of portfolio
-
Harvey Partners, LLC Tarrytown, NY2.56MShares$6.01 Million0.9% of portfolio
-
Amh Equity LTD2.2MShares$5.17 Million8.75% of portfolio
-
Granahan Investment Management, LLC Waltham, MA1.93MShares$4.52 Million0.23% of portfolio
About HARVARD BIOSCIENCE INC
- Ticker HBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 41,636,500
- Market Cap $97.8M
- Description
- Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...